Overview
Approaches to Acute Iliofemoral Deep Vein Thrombosis: Medical and Endovascular Management
CME Touchpoint
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
881315.png)
Nearly half of all patients with deep vein thrombosis (DVT) go on to develop post-thrombotic syndrome (PTS). This CME-certified, 30-minute touchpoint features an expert interventional radiologist, Dr. Kush Desai from Northwestern Medicine, and includes video commentary on key clinical trial data and patient selection for endovascular interventions to reduce the risk of PTS. Dr. Desai also addresses the impact and severity of PTS, and the role of interventions in improving patient quality of life.
Featured topic areas include:
• The burden of PTS
• Clinical trials that examine the use of catheter directed interventional methods for improving outcomes after DVT
• Procedural considerations: Device management
• How I do it case on a patient who presents with iliofemoral DVT
This activity is intended for interventional cardiologists, interventional radiologists, vascular surgeons, and other healthcare clinicians interested in treating patients with venous disease.
Despite advancements in the medical treatment of DVT, including novel oral anticoagulants that do not require routine monitoring, nearly half of all patients go on to develop post-thrombotic syndrome (PTS). Endovascular interventions have shown promise, particularly in iliofemoral DVT, to address more severe symptoms, potentially reduce the severity of PTS, and improve quality of life. Physicians need to stay up-to-date on the guideline recommendations for the medical management of DVT and how to prevent PTS in patients.
Upon completion of this activity, participants will be able to:
• Discuss the risk factors for development of post-thrombotic syndrome (PTS) following acute deep vein thrombosis (DVT), as well as the impact of PTS on patient quality of life
• Outline available devices for percutaneous mechanical/pharmacochemical thrombectomy and catheter-directed thrombolysis for managing acute DVT
• Interpret and apply data from clinical trials that have compared medical therapy with endovascular DVT intervention to deliver optimal, evidence-based care
• Discuss the risk factors for development of post-thrombotic syndrome (PTS) following acute deep vein thrombosis (DVT), as well as the impact of PTS on patient quality of life
• Outline available devices for percutaneous mechanical/pharmacochemical thrombectomy and catheter-directed thrombolysis for managing acute DVT
• Interpret and apply data from clinical trials that have compared medical therapy with endovascular DVT intervention to deliver optimal, evidence-based care
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Boston Scientific Corporation.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Kush Desai, MD, FSIR
Associate Professor of Radiology, Surgery, and Medicine
Division of Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, IL
Associate Professor of Radiology, Surgery, and Medicine
Division of Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, IL
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Devices under investigation for DVT
The following financial relationships have been provided:
Kush Desai, MD, FSIR, (Faculty)
Consultant: Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Cook Medical, Cordis, C. R. Bard, W. L. Gore & Associates, Inc., Medtronic, OptiMed, Philips, Tactile Medical, Walk Vascular
Speakers' Bureau: Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical, C. R. Bard
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Devices under investigation for DVT
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material initially launched on October 8, 2020. The content was re-reviewed for scientific validity and accuracy on February 16, 2022 and April 7, 2023. Accreditation for this activity will expire on February 3, 2024.
